Rodin Therapeutics, Inc. — Form D
Rodin Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-14. The offering totals $27.1M, of which $10.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-09-14
- Form: D
- Accession: 0001716694-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $27.1M
- Amount sold: $10.8M
- Remaining: $16.2M
- Investors: 6
- Date of first sale: 2017-08-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-294765
Issuer
- Name: Rodin Therapeutics, Inc.
- CIK: 0001716694
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 300 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139
- Phone: (857) 201-2770
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Kees Been | Director | Cambridge, MA |
| Bruce Booth | Director | Cambridge, MA |
| Adam Rosenberg | Director | Wilmington, DE |
| SAMANTHA SINGER | Director | WATERTOWN, MA |
| Adam Rosenberg | Executive Officer | Wilmington, DE |
More